Entering text into the input field will update the search result below

MediciNova receives new European patent for ibudilast for alcohol use disorder

Jan. 27, 2022 6:43 AM ETMediciNova, Inc. (MNOV) StockBy: SA News Team

Business woman signs a patent. Intellectual property protection concept. Patent attorney.

Irina Vodneva/iStock via Getty Images

  • MediciNova (NASDAQ:MNOV) has received a Notice of Intention to Grant from the European Patent Office for a pending patent application which covers MN-166 (ibudilast) for the treatment of alcohol use disorder.
  • Once issued, the patent is expected to

Recommended For You

More Trending News

About MNOV Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MNOV--
MediciNova, Inc.